By

The panel will discuss cross-border M&A trends in the face of current geopolitical and financial turbulence, including the after-effects of the Pandemic, Russia-Ukraine war, and China’s economic threat. We will address transactional opportunities and structures, due diligence...

Healthcare industry’s post-pandemic resilience and scale continue to attract capital and drive consolidation.  The panel will discuss transactional drivers and headwinds, such as supply chain disruptions and increasing labor costs, financing challenges, systemic distress and...

The panel will discuss most common M&A risks and ways to mitigate them, including deal structures, corporate governance and ESG, due diligence and investigations, integration planning and transactional insurance, as well as address questions from the audience. LEADING FIRMS...

With the disruptions of the pandemic largely behind us, multinationals and private equity investors are targeting Latin America company acquisitions to leverage natural resource availability, lower labor costs and expanding consumer market demand. The panel will discuss current...

The panel will focus on current regulatory and compliance issues in the Cannabis industry domestically and internationally and their effect on corporate valuations, due diligence, capital investment activity and mergers and acquisitions. Speakers will also address industry...

The panel will discuss structural and disclosure, regulatory and accounting considerations, as well as internal controls and corporate governance issues arising in SPAC transactions as well as potential conflicts and litigation risks, including SEC scrutiny and private lawsuits.

Maturing cannabis industry is projected to reach sales of $70 billion by 2028 (Bloomberg).  The panel will discuss industry growth drivers, consolidation trends, restructuring alternatives, risk management, role of IP, access to capital, cross-border activity, valuations and...

The panel will discuss transactional activity in various healthcare verticals, deal drivers and challenges, technology and competitive pressures, deal structures and capital availability, and opportunities for private equity investors in the time of uncertainty. We will also...

WATCH THE REPLAY The COVID-19 pandemic has not slowed the dealmaking.  On the contrary, 2021 turned out to be a record year in terms of M&A volume, with $5.9 trillion in deals.  Yet, the deal process and due diligence practices were greatly impacted by the “New Normal.” The...

WATCH THE REPLAY 2021 global M&A volume exceeded exceeded $5.9 trillion, much of it attributable to technology companies.  During the pandemic, technology has become the driving force for change in virtually every industry, resulting in many corporate transformations and...